Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis.

Medicine (Baltimore) · 2020 · PMC7220154 · PMID 32221093

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

The group that received this treatment demonstrated a favorable trend in median survival (12.5 months vs 7 months), 1 and 2-yrs OSR (55.6% vs 33.3% and 17.7% vs 11.1%), longer PFS, median PFS (6 months vs 3 months), 1 and 2-yrs PFS (25% vs 11.1% and 15.2% vs 8.3%).

also in 1,335 other papers

did not reach statistical significanceno p-value reported

Unfortunately, the P value did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.